Clinical trial
A Single-center, Randomized, 6-month, Non-inferiority Study to Compare the Safety and Efficacy of TICAgreLor mONotherapy Versus Dual Antiplatelet Therapy in Chronic Coronary Syndrome Patients Post Percutaneous Coronary IntErvention (TICALONE)
NCT06509893 is registered in ClinicalTrials.gov with Shiraz University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-center, Randomized, 6-month, Non-inferiority Study to Compare the Safety and Efficacy of TICAgreLor mONotherapy Versus Dual Antiplatelet Therapy in Chronic Coronary Syndrome Patients Post Percutaneous Coronary IntErvention (TICALONE)
- Lead sponsor
- Shiraz University of Medical Sciences
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- August 1, 2024
- Completion date
- May 1, 2026
- Enrollment
- 5,400 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.